Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Von Hippel-Lindau gene product modulates TIS11B expression in renal cell carcinoma: impact on vascular endothelial growth factor expression in hypoxia.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Von Hippel-Lindau gene product modulates TIS11B expression in renal cell carcinoma: impact on vascular endothelial growth factor expression in hypoxia.
Von Hippel-Lindau gene product modulates TIS11B expression in renal cell carcinoma: impact on vascular endothelial growth factor expression in hypoxia. J Biol Chem. 2009 Nov 20; 284(47):32610-8.
View in:
PubMed
subject areas
Butyrate Response Factor 1
Butyrate Response Factor 1
Carcinoma, Renal Cell
Carcinoma, Renal Cell
Cell Line, Tumor
Cell Line, Tumor
Down-Regulation
Down-Regulation
Gene Expression Regulation, Neoplastic
Gene Expression Regulation, Neoplastic
Gene Silencing
Gene Silencing
Humans
Humans
Hypoxia
Hypoxia
Liver Neoplasms
Liver Neoplasms
Models, Biological
Models, Biological
Oxygen
Oxygen
RNA Interference
RNA Interference
RNA, Messenger
RNA, Messenger
Vascular Endothelial Growth Factor A
Vascular Endothelial Growth Factor A
Von Hippel-Lindau Tumor Suppressor Protein
Von Hippel-Lindau Tumor Suppressor Protein
authors with profiles
Asish K Ghosh